Stocklytics Platform
Asset logo for symbol ARWR
Arrowhead Pharmaceuticals
ARWR48
$28.11arrow_drop_down0.49%-$0.14
Asset logo for symbol ARWR
ARWR48

$28.11

arrow_drop_down0.49%

AI Deep-Learning Forecast (ARWR)

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Arrowhead Pharmaceuticals (ARWR) Stocklytics Forecast

Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company specializing in the development of RNAi-based therapeutics. With a strong pipeline and promising clinical results, many investors are looking for a price prediction for ARWR stock. While it's impossible to predict the exact future price of a stock, there are several factors that may influence ARWR's stock price in the coming years.

One factor that may impact ARWR's stock price is the company's ongoing clinical trials. Arrowhead Pharmaceuticals has a number of drug candidates in various stages of development, targeting a range of diseases including liver diseases, cardio-metabolic diseases, and oncology. Positive results from these trials could boost investor confidence and drive up the stock price.

add Arrowhead Pharmaceuticals  to watchlist

Keep an eye on Arrowhead Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is the analyst price prediction for Arrowhead Pharmaceuticals (ARWR) stock?

Analysts have set a target price of $56.71 for Arrowhead Pharmaceuticals (ARWR), based on forecasts from 28 analysts. The predicted price range extends from a high of $90 to a low of $27. This represents a potential increase of up to 220.17% and a decrease of -3.95% from the current price of $28.11. These forecasts are as of 2023 May 03.

help
What are the analyst ratings for Arrowhead Pharmaceuticals (ARWR) stock?

The analyst ratings for Arrowhead Pharmaceuticals (ARWR) are distributed as follows: 1 analysts recommend buying, 3 have a neutral stance, and 0 suggest selling. The prevailing sentiment among the total of 4 analysts leans towards a neutral rating. These ratings indicate the general sentiment among the analysts covering Arrowhead Pharmaceuticals .

help
What is the AI price prediction for Arrowhead Pharmaceuticals (ARWR) stock?

At present, there is no AI or machine-learning-based price prediction available for Arrowhead Pharmaceuticals (ARWR) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level